Michael Atkin

Vorstandsvorsitzender bei

Ulysses Pharmaceuticals Products, Inc.

70 Jahre

Health Technology

Consumer Services

Profil

Michael C.
Atkin is the founder of Syzent Partners Ltd. founded in 2008, where he holds the title of President.
He currently holds the positions of Executive Chairman, President & CEO at Ulysses Pharmaceuticals Products, Inc. and Director at Affinite Instruments.
Mr. Atkin's former positions include President & Chief Executive Officer at Aegera Therapeutics, Inc., President, Chief Executive Officer & Secretary at Gladius Pharmaceuticals Corp., Chairman at ChitogenX, Inc., Chairman at Sopharmia, Inc., Director at Genizon Biosciences, Inc., Director at Topigen Pharmaceuticals, Inc., and Principal at Bristol Myers Squibb Co. He also held the position of Vice President-Business Development at Lederle International.
Mr. Atkin received his undergraduate degree from the University of Kent and his MBA from Columbia Business School.

Aktive Positionen von Michael Atkin

Unternehmen	Position	Beginn
Ulysses Pharmaceuticals Products, Inc. Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections	Vorstandsvorsitzender	-
Syzent Partners Ltd.	Gründer	01.01.2008
Affinite Instruments Affinite Instruments Medical SpecialtiesHealth Technology Develops and manufactures SPR instruments	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Michael Atkin

Ehemalige bekannte Positionen von Michael Atkin

Unternehmen	Position	Ende
CHITOGENX INC.	Vorsitzender	01.07.2022
Gladius Pharmaceuticals Corp. Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Operates as biotechnology firm	Vorstandsvorsitzender	01.01.2019
Genizon Biosciences, Inc. Genizon Biosciences, Inc. BiotechnologyHealth Technology Provides drug development services	Direktor/Vorstandsmitglied	30.05.2012
Sopharmia, Inc.	Vorsitzender	-
Lederle International	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Michael Atkin im Detail an

Ausbildung von Michael Atkin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Michael Atkin im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	13
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Genizon Biosciences, Inc. Genizon Biosciences, Inc. BiotechnologyHealth Technology Provides drug development services	Health Technology
Aegera Therapeutics, Inc. Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs	Health Technology
Topigen Pharmaceuticals, Inc. Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases	Health Technology
Lederle International
Ulysses Pharmaceuticals Products, Inc. Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections	Health Technology
University of Kent University of Kent Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Columbia Business School Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gladius Pharmaceuticals Corp. Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Operates as biotechnology firm	Health Technology
ChitogenX, Inc. ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company	Health Technology
Syzent Partners Ltd.
Sopharmia, Inc.
Affinite Instruments Affinite Instruments Medical SpecialtiesHealth Technology Develops and manufactures SPR instruments	Health Technology